Organic acids and derivatives
Medchemexpress LLC PF-06424439 methanesulfonate | 1469284-79-4 | 99.9% | 536.05 g/mol | C23H30ClN7O4S | 100 MG
PF-06424439 methanesulfonate is the methanesulfonate salt form of a potent, selective small-molecule inhibitor of diacylglycerol acyltransferase 2 (DGAT2). It is supplied as a high-purity solid for preclinical research to study triglyceride synthesis and lipid metabolism in biochemical, cellular, and animal models.
- Potent, selective DGAT2 inhibitor (IC50 14 nM).
- High purity suitable for research applications.
- Methanesulfonate salt to aid solubility and handling.
- Suitable for in vitro and in vivo preclinical studies.
- Supplied as a 100 mg pack for controlled dosing.
Medchemexpress LLC PF-06424439 methanesulfonate | 1469284-79-4 | 99.9% | 536.05 g/mol | C23H30ClN7O4S | 25 MG
PF-06424439 methanesulfonate is a research-grade small-molecule inhibitor of diacylglycerol acyltransferase 2 (DGAT2). It is a potent, selective imidazopyridine that inhibits DGAT2 noncompetitively (IC50 = 14 nM) and exhibits slowly reversible, time-dependent inhibition. Supplied as a methanesulfonate salt for laboratory research.
- Potent, selective DGAT2 inhibitor (IC50 = 14 nM).
- Noncompetitive, slowly reversible, time-dependent mode of inhibition.
- High purity (99.9%).
- Solid, white to yellow physical form.
- High solubility in DMSO and water for in vitro use (DMSO 250 mg/mL; H2O 50 mg/mL).
- Available in small pack sizes suitable for preclinical research.
Apexbio Technology LLC Pridinol Methanesulfonate 6856-31-1 1g
Pridinol Methanesulfonate (CAS 6856-31-1) is a synthetic small molecule classified as an anticholinergic compound It exerts its pharmacological effects primarily by inhibiting muscarinic acetylcholine receptors thereby reducing cholinergic neurotransmission within the central nervous system This mechanism underlies its application as an antiparkinsonian agent in biomedical research where it is utilized to study neuromuscular transmission and motor control disorders associated with altered cholinergic signaling Pridinol Methanesulfonate serves as a valuable tool for investigating the pathophysiology of movement disorders and evaluating novel therapeutics that target cholinergic pathways
Medchemexpress LLC Ethyl methanesulfonate-d5 | 1219795-44-4 | 99.5% | 129.19 | C3H3D5O3S | 5 MG
Ethyl methanesulfonate-d5 is a deuterium-labeled analogue of ethyl methanesulfonate intended for use as an internal standard and tracer in analytical and drug metabolism studies. The product is provided as a high-purity isotopically labeled liquid with accompanying documentation for laboratory use and recommended storage conditions.
- Deuterium-labeled internal standard for quantitative analysis.
- High purity for accurate and reproducible results.
- Compatible with NMR, GC-MS, and LC-MS workflows.
- Available in small vials suitable for analytical applications.
- Includes datasheet, certificate of analysis, and safety data sheet.
- Stable under recommended storage conditions for long-term use.
Medchemexpress LLC Phenamil methanesulfonate | 1161-94-0 | 98.1% | 401.83 | 50 MG
Phenamil methanesulfonate | 1161-94-0 | 98.1% | 401.83 | 50 MG
Apexbio Technology LLC Pridinol Methanesulfonate 6856-31-1 10mM (in 1mL DMSO)
Pridinol Methanesulfonate (CAS 6856-31-1) is a synthetic small molecule classified as an anticholinergic compound It exerts its pharmacological effects primarily by inhibiting muscarinic acetylcholine receptors thereby reducing cholinergic neurotransmission within the central nervous system This mechanism underlies its application as an antiparkinsonian agent in biomedical research where it is utilized to study neuromuscular transmission and motor control disorders associated with altered cholinergic signaling Pridinol Methanesulfonate serves as a valuable tool for investigating the pathophysiology of movement disorders and evaluating novel therapeutics that target cholinergic pathways
eMolecules 1193111-39-5 | Medchem Express | sulfo-SPDB | 5mg | 518571418 | HY-101151 | MFCD20227457 | 406.44 | C13H14N2O7S3
Pharmablock | tert-butyl 4-cyanoazepane-1-carboxylate | 25mg | 551271778 | PBN20121441 | 1259056-34-2 | MFCD18088875 | 224.304 | C12H20N2O2
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
![eMolecules 1630906-98-7 | tert-butyl 4-[3-(methanesulfonyloxy)propyl]piperazine-1-carboxylate hydrochloride | Pharmablock | MFCD28166268 | 358.880 | C13H27ClN2O5S | 97.000 | Cl.CC(C)(C)OC(=O)N1CCN(CCCOS(C)(=O)=O)CC1 | 50mg | 586151069](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502515997.JPG-250.jpg)
eMolecules 1630906-98-7 | tert-butyl 4-[3-(methanesulfonyloxy)propyl]piperazine-1-carboxylate hydrochloride | Pharmablock | MFCD28166268 | 358.880 | C13H27ClN2O5S | 97.000 | Cl.CC(C)(C)OC(=O)N1CCN(CCCOS(C)(=O)=O)CC1 | 50mg | 586151069
tert-butyl 4-[3-(methanesulfonyloxy)propyl]piperazine-1-carboxylate hydrochloride | Pharmablock | 1630906-98-7 | MFCD28166268 | 358.880 | C13H27ClN2O5S | 97.000 | Cl.CC(C)(C)OC(=O)N1CCN(CCCOS(C)(=O)=O)CC1 | 50mg | 586151069
eMolecules 534-03-2 | 2-Aminopropane-1,3-diol | Apollo Scientific US - Building Blocks | MFCD00051487 | 91.110 | C3H9NO2 | 98.000 | NC(CO)CO | 500g | 398000212
2-Aminopropane-1,3-diol | Apollo Scientific US - Building Blocks | 534-03-2 | MFCD00051487 | 91.110 | C3H9NO2 | 98.000 | NC(CO)CO | 500g | 398000212
eMolecules Broadpharm / Sulfo-NHS-Acetate / 500mg / 279709207 / BP-22666 / 92.000 / 152305-87-8 / MFCD00054979 / 259.160 / C6H6NNaO7S
Broadpharm / Sulfo-NHS-Acetate / 500mg / 279709207 / BP-22666 / 92.000 / 152305-87-8 / MFCD00054979 / 259.160 / C6H6NNaO7S